Cite
MLA Citation
H. Glen et al.. “432 Correlative analyses of serum biomarkers and clinical outcomes in the phase 2 study of lenvatinib, everolimus, and the combination, in patients with metastatic renal cell carcinoma following 1 VEGF-targeted therapy.” European journal of cancer, vol. 51, n.d., pp. S89–. http://access.bl.uk/ark:/81055/vdc_100030628020.0x000016